Neuro.net Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Neuro.net's estimated annual revenue is currently $8M per year.(i)
  • Neuro.net's estimated revenue per employee is $130,500

Employee Data

  • Neuro.net has 61 Employees.(i)
  • Neuro.net grew their employee count by -22% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.9M294%N/AN/A
#2
$43.4M2728%N/AN/A
#3
$14.1M9711%N/AN/A
#4
$1460M82917%$1.1BN/A
#5
$310M152720%N/AN/A
#6
$194.1M956-5%N/AN/A
#7
$223.9M1080-33%$101.6MN/A
#8
$581.3M27089%$253.1MN/A
#9
$716.2M35282%N/AN/A
#10
$801.4M394852%N/AN/A
Add Company

Neuro.net team develops Voice AI that sounds indistinguishable from humans. We have replaced more than 100,000 contact center employees with our virtual agents. They are able to support complex conversations and mimic emotions. In 300 million dialogues, 99% of respondents did not recognize the customer service agent as being an AI driven virtual agents.

keywords:N/A

N/A

Total Funding

61

Number of Employees

$8M

Revenue (est)

-22%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Neuro.net's People

NameTitleEmail/Phone
1
FounderReveal Email/Phone

Neuro.net News

2022-04-20 - 2022-04-28 | NYSE:SYK | Press Release | STRYKER ...

MedSurg and Neurotechnology net sales of $2.4 billion increased 10.6% in the quarter and 12.1% in constant currency.

2022-04-17 - Head to Head Survey: NeuroOne Medical Technologies ...

This table compares NeuroOne Medical Technologies and ClearPoint Neuro's net margins, return on equity and return on assets.

2022-04-17 - Alzamend Neuro, Inc. (NASDAQ:ALZN) Major Shareholder ...

Alzamend Neuro, Inc. (NASDAQ:ALZN) Major Shareholder Buys $70,500.00 in Stock. Posted by admin on Apr 25th, 2022.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8M6165%N/A
#2
$7.4M61-8%$20.5M
#3
$8M610%N/A
#4
$8M61-10%N/A
#5
$8M61-2%N/A